vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and HCI Group, Inc. (HCI). Click either name above to swap in a different company.
HCI Group, Inc. is the larger business by last-quarter revenue ($246.2M vs $205.4M, roughly 1.2× COLLEGIUM PHARMACEUTICAL, INC). HCI Group, Inc. runs the higher net margin — 39.7% vs 8.3%, a 31.4% gap on every dollar of revenue. On growth, HCI Group, Inc. posted the faster year-over-year revenue change (52.1% vs 12.9%). HCI Group, Inc. produced more free cash flow last quarter ($440.8M vs $122.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 9.2%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
HCI Equity Partners is a Washington, DC–based private equity firm with an additional office in Chicago, Illinois.
COLL vs HCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $246.2M |
| Net Profit | $17.0M | $97.7M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 58.5% |
| Net Margin | 8.3% | 39.7% |
| Revenue YoY | 12.9% | 52.1% |
| Net Profit YoY | 35.3% | 3679.2% |
| EPS (diluted) | $0.48 | $7.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $246.2M | ||
| Q3 25 | $209.4M | $216.3M | ||
| Q2 25 | $188.0M | $221.9M | ||
| Q1 25 | $177.8M | $216.4M | ||
| Q4 24 | $181.9M | $161.9M | ||
| Q3 24 | $159.3M | $175.3M | ||
| Q2 24 | $145.3M | $206.2M | ||
| Q1 24 | $144.9M | $206.6M |
| Q4 25 | $17.0M | $97.7M | ||
| Q3 25 | $31.5M | $65.5M | ||
| Q2 25 | $12.0M | $66.2M | ||
| Q1 25 | $2.4M | $69.7M | ||
| Q4 24 | $12.5M | $2.6M | ||
| Q3 24 | $9.3M | $5.7M | ||
| Q2 24 | $19.6M | $54.1M | ||
| Q1 24 | $27.7M | $47.6M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | 58.5% | ||
| Q3 25 | 29.7% | 41.9% | ||
| Q2 25 | 18.7% | 42.5% | ||
| Q1 25 | 12.2% | 46.4% | ||
| Q4 24 | 20.9% | 3.6% | ||
| Q3 24 | 21.9% | 8.0% | ||
| Q2 24 | 32.7% | 36.9% | ||
| Q1 24 | 34.1% | 37.5% |
| Q4 25 | 8.3% | 39.7% | ||
| Q3 25 | 15.0% | 30.3% | ||
| Q2 25 | 6.4% | 29.8% | ||
| Q1 25 | 1.4% | 32.2% | ||
| Q4 24 | 6.9% | 1.6% | ||
| Q3 24 | 5.9% | 3.2% | ||
| Q2 24 | 13.5% | 26.2% | ||
| Q1 24 | 19.1% | 23.0% |
| Q4 25 | $0.48 | $7.29 | ||
| Q3 25 | $0.84 | $4.90 | ||
| Q2 25 | $0.34 | $5.18 | ||
| Q1 25 | $0.07 | $5.35 | ||
| Q4 24 | $0.36 | $0.32 | ||
| Q3 24 | $0.27 | $0.52 | ||
| Q2 24 | $0.52 | $4.24 | ||
| Q1 24 | $0.71 | $3.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $1.2B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $1.0B |
| Total Assets | $1.7B | $2.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $1.2B | ||
| Q3 25 | $285.9M | $987.9M | ||
| Q2 25 | $222.2M | $947.2M | ||
| Q1 25 | $197.8M | $754.5M | ||
| Q4 24 | $162.8M | $532.5M | ||
| Q3 24 | $120.0M | $518.8M | ||
| Q2 24 | $271.6M | $445.8M | ||
| Q1 24 | $318.0M | $655.4M |
| Q4 25 | $301.7M | $1.0B | ||
| Q3 25 | $274.8M | $821.8M | ||
| Q2 25 | $232.2M | $758.6M | ||
| Q1 25 | $234.4M | $522.7M | ||
| Q4 24 | $228.8M | $453.3M | ||
| Q3 24 | $234.3M | $455.3M | ||
| Q2 24 | $216.6M | $447.3M | ||
| Q1 24 | $222.2M | $395.7M |
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.6B | $2.3B | ||
| Q2 25 | $1.6B | $2.4B | ||
| Q1 25 | $1.6B | $2.3B | ||
| Q4 24 | $1.7B | $2.2B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.1B | $1.9B | ||
| Q1 24 | $1.1B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $444.4M |
| Free Cash FlowOCF − Capex | $122.4M | $440.8M |
| FCF MarginFCF / Revenue | 59.6% | 179.0% |
| Capex IntensityCapex / Revenue | 0.3% | 1.5% |
| Cash ConversionOCF / Net Profit | 7.25× | 4.55× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $771.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $444.4M | ||
| Q3 25 | $78.4M | $26.7M | ||
| Q2 25 | $72.4M | $145.0M | ||
| Q1 25 | $55.4M | $162.0M | ||
| Q4 24 | $84.6M | $331.8M | ||
| Q3 24 | $-9.0M | $104.1M | ||
| Q2 24 | $67.4M | $-29.0M | ||
| Q1 24 | $61.9M | $182.0M |
| Q4 25 | $122.4M | $440.8M | ||
| Q3 25 | $78.3M | $25.9M | ||
| Q2 25 | $72.4M | $144.5M | ||
| Q1 25 | $54.6M | $160.3M | ||
| Q4 24 | $84.1M | $327.8M | ||
| Q3 24 | $-9.2M | $103.2M | ||
| Q2 24 | $67.1M | $-30.1M | ||
| Q1 24 | $61.4M | $181.0M |
| Q4 25 | 59.6% | 179.0% | ||
| Q3 25 | 37.4% | 12.0% | ||
| Q2 25 | 38.5% | 65.1% | ||
| Q1 25 | 30.7% | 74.1% | ||
| Q4 24 | 46.2% | 202.5% | ||
| Q3 24 | -5.8% | 58.9% | ||
| Q2 24 | 46.2% | -14.6% | ||
| Q1 24 | 42.3% | 87.6% |
| Q4 25 | 0.3% | 1.5% | ||
| Q3 25 | 0.1% | 0.4% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 0.3% | 2.5% | ||
| Q3 24 | 0.2% | 0.5% | ||
| Q2 24 | 0.2% | 0.5% | ||
| Q1 24 | 0.4% | 0.5% |
| Q4 25 | 7.25× | 4.55× | ||
| Q3 25 | 2.49× | 0.41× | ||
| Q2 25 | 6.05× | 2.19× | ||
| Q1 25 | 22.92× | 2.32× | ||
| Q4 24 | 6.75× | 128.41× | ||
| Q3 24 | -0.96× | 18.33× | ||
| Q2 24 | 3.44× | -0.54× | ||
| Q1 24 | 2.23× | 3.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
HCI
| Insurance Operation | $218.3M | 89% |
| Reciprocal Exchange Operation | $27.0M | 11% |
